Skip to main content
Premium Trial:

Request an Annual Quote

John DelliSanti

Caliper Life Sciences has named John DelliSanti to the posts of executive vice president and COO. In the job, DelliSanti will oversee the company’s worldwide sales, marketing, and services functions.
DelliSanti previously led Invitrogen’s American commercial operations, worked in international sales and services at Accelrys for a dozen years, and worked for Wyeth Pharmaceuticals and Hitachi Instruments.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.